Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer - experience from a prematurely closed phase II study

被引：8
|
作者：
Raez, LE [1 ]
Rosado, MF [1 ]
Santos, ES [1 ]
Reis, IM [1 ]
机构：
[1] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol Oncol, Miami, FL 33136 USA
来源：
LUNG CANCER | 2004年 / 45卷 / 01期
关键词：
D O I：
10.1016/j.lungcan.2004.01.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：131 / 132
页数：2
相关论文
共 50 条
  • [31] A PHASE II STUDY OF FIRST-LINE BORTEZOMIB (B) IN PATIENTS (PTS) WITH STAGE IIIB/IV NON-SMALL-CELL LUNG CANCER (NSCLC)
    Planchard, D.
    Besse, B.
    Meric, J. B.
    Veillard, A. S.
    Pignon, J. P.
    Chan, K.
    Mathiot, C.
    Lumbroso, J.
    Lafontaine, C.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 96 - 96
  • [32] Phase II study of navelbine and carboplatin in stage IIIB and IV non small cell lung cancer
    Chetiyawardana, AD
    Grove, N
    Faulk, S
    THORAX, 2001, 56 : 69 - 69
  • [33] Results of a Phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age ≤65 and performance status 2
    Weissman, CH
    Sandbach, J
    Brooker, R
    Vellek, M
    Lindquist, D
    Conkling, P
    Llegbodu, D
    Asmar, L
    LUNG CANCER, 2006, 52 (03) : 313 - 317
  • [34] A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer
    Blakely, L. Johnetta
    Schwartzberg, Lee
    Keaton, Mark
    Schnell, Fred
    Henry, David
    Epperson, Amanda
    Walker, Mark S.
    LUNG CANCER, 2009, 66 (01) : 97 - 102
  • [35] Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: A multicentre phase II study
    Ziotopoulos, P
    Androulakis, N
    Mylonaki, E
    Chandrinos, V
    Zachariadis, E
    Boukovinas, I
    Agelidou, A
    Kentepozidis, N
    Ignatiadis, M
    Vossos, A
    Georgoulias, V
    LUNG CANCER, 2005, 50 (01) : 115 - 122
  • [36] Study on concomitant radiotherapy and chemotherapy combined with endostatin for IIIb and IV stage non-small cell lung cancer
    Li, T.
    Liu, L. I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 532 - 532
  • [37] Phase II study of 3-week scheduled therapy with irinotecan (I) plus cisplatin (P) in patients with stage IIIB or IV non-small cell lung cancer
    Saito, Hiroshi
    Kudo, Shinzo
    Nakagawa, Kazuhiko
    Negoro, Shun-ichi
    Matsui, Kaoru
    Senba, Hiroshi
    Ueshima, Hisao
    Takada, Minoru
    ANNALS OF ONCOLOGY, 2004, 15 : 178 - 179
  • [38] Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and Stage IV non-small cell lung cancer
    Charles M. Haskell
    Evelyn Mendoza
    Katherine M.W. Pisters
    Frank V. Fossella
    Robert A. Figlin
    Investigational New Drugs, 1998, 16 : 81 - 85
  • [39] Phase II study of intravenous adenosine 5′-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer
    Haskell, CM
    Mendoza, E
    Pisters, KMW
    Fossella, FV
    Figlin, RA
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 81 - 85
  • [40] Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer
    Zatloukal, Petr
    Gervais, Radj
    Vansteenkiste, Johan
    Bosquee, Leon
    Sessa, Christiana
    Brain, Etienne
    Dansin, Eric
    Urban, Thierry
    Dohollou, Nadine
    Besenval, Michele
    Quoix, Elisabeth
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 894 - 901
12345